Deciphex
PrivateLast Round
Debt
Oct 1, 2025
Total Funding Raised
$93.78M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Deciphex operates in Healthcare & Life Sciences and is based in Dublin. Its latest recorded funding round was a Debt round in October 2025.
Deciphex is a health technology company that develops artificial intelligence-powered digital pathology software and provides services to accelerate pathology diagnostics for clinical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Drug Discovery, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deciphex Comparables
Compare Deciphex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRA Matrix | 86% | |
| Proscia | 85% | |
| Visiopharm | 83% |
For institutional investors. Book with your work email.
Deciphex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Oct 1, 2025 | ||||
| Series C | Jan 7, 2025 | ||||
| Debt | Oct 16, 2023 | ||||
| Series B Extension | Jan 25, 2023 | ||||
| Series B | May 19, 2022 | ||||
Series A | Jul 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Deciphex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ACT Venture Capital | Series C, Series B Extension, Series A, Seed, Series B |
| Claret Capital Partners | Debt |
| Seroba Life Sciences | Series C, Series B Extension |
| GI Partners | Series A, Seed |
| Inova Personalized Health Accelerator | Seed |
| NextSteps Capital | Series C, Series B, Series B Extension, Series A, Seed |
| Department of Enterprise, Trade and Employment | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 199% MoM, reaching 4.8K.
- Jul 20, 2026
Open roles increased to 222, 3.9x the trailing average.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresNov 11, 2026
Deciphex appoints Stephen White as Chief Compliance & Risk Officer (CCRO) to strengthen its executive leadership as it expands its clinical diagnostics and research pathology businesses worldwide on Nov 11th '26 in Ireland.
- hiresNov 11, 2026
Deciphex hires Steve White as Chief Compliance & Risk Officer to translate global regulatory requirements into practical guidance and strengthen quality, security, privacy, and commercial compliance.
- hiresNov 11, 2026
Deciphex appoints Stephen White as Chief Compliance & Risk Officer on Nov 11th '26 in Ireland, strengthening its executive leadership as it expands its clinical diagnostics and research pathology businesses worldwide.
For institutional investors. Book with your work email.
Deciphex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deciphex's valuation, stock price, and market status.
Is Deciphex a public or private company?
Deciphex is a private company.
What is the current stock price of Deciphex?
Deciphex is a private company, so its shares have no public market price. Caplight tracks Deciphex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deciphex worth (valuation)?
Valuation information for Deciphex is not publicly available.
Can I buy Deciphex stock?
Deciphex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deciphex's last funding round?
Deciphex's most recent funding round was Debt on October 1, 2025.
Who are the main investors in Deciphex?
Key investors in Deciphex include ACT Venture Capital, Claret Capital Partners, Seroba Life Sciences, Molten Ventures.
Will Deciphex IPO soon?
No public IPO plans have been announced for Deciphex.
How can I track Deciphex secondary market activity?
Caplight tracks bids, offers, and trades in Deciphex's shares on secondary markets.